Korro Bio is a Biotech company based in Cambridge. It has raised $162M in total funding. Latest round: Series A.
Korro Bio funding overview
Korro Bio is a Biotech company based in Cambridge. Korro Bio has raised $162M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Korro Bio runs through 2021; nothing later has been disclosed. Investors on record include Atlas Venture, New Enterprise Associates, Wu Capital, Qiming Venture Partners USA, Surveyor Capital. 5 distinct backers are named across the disclosed rounds.
Korro Bio at a glance
Total raised
$162M
Latest round
Series A
Latest round date
September 2021
Industry
Biotech
Headquarters
Cambridge
Notable investors
Atlas Venture, New Enterprise Associates, Wu Capital, Qiming Venture Partners USA, Surveyor Capital
Frequently asked about Korro Bio funding
How much has Korro Bio raised?
Korro Bio has raised $162M in total disclosed funding across the rounds on record.
Who has invested in Korro Bio?
Atlas Venture, New Enterprise Associates, Wu Capital, Qiming Venture Partners USA, Surveyor Capital are named among the investors backing Korro Bio.
What was the latest Korro Bio funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is Korro Bio based?
Korro Bio is based in Cambridge.
What sector does Korro Bio operate in?
Korro Bio is tracked under Biotech from Cambridge, with $162M in disclosed funding.
When did Korro Bio last raise?
The last disclosed Korro Bio round closed in September 2021 at Series A.
We update the Korro Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
